Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer

• Ji Son,
• Katherine E. Cain,
• Claire A. Marten,
• Kaitlin W Dwyer,
• Travis T. Sims,
• Jolyn S. Taylor

Affiliations

Ji Son

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Katherine E. Cain

Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Claire A. Marten

Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Kaitlin W Dwyer

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Travis T. Sims

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jolyn S. Taylor

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Corresponding author.